Is Cyberknife a good prostate cancer treatment?
https://youtu.be/JnnE7X4tRZc Precision Radiation Treatment . Cyberknife has improved prostate cancer treatment as dynamically as robotic surgery . But, Cyberknife is not for everyone. See if it's right for you. Seth Blacksburg, MD and Darryl [...]
Emotional Crisis Resources From Malecare
Malecare's collection of emotion crisis resources. Call these, even if you don't know if you "really" need them. Many international calls are free or affordable with SKYPE and many other apps. Feel OK about [...]
Prostate Cancer And Agent Orange Is Not The Only Military Concern
Agent Orange is usually the first thing veterans with prostate cancer ask about. Indeed, way back in 1998, Malecare was an early advocate for men exposed to Agent Orange. Military veterans as well as [...]
Erleada- New Treatment for Non-Metastatic Castrate Resistant Prostate Cancer
Erleada (apalutamide) has just received FDA approval as a drug for treating men with non-metastatic castration-resistant prostate cancer. The proper pronunciation is Er ( Errr), (Like Her without the h) ) (lee) (long [...]
Apalutamide Looking Good as Treatment for Non-Metastatic Castrate Resistant Prostate Cancer
Non-Metastatic Castrate Resistant Prostate Cancer (nmCRPC) usually leads to metastatic prostate cancer and death. There are no approved treatments for nmCRPC. Apalutamide is a taken-by-mouth androgen receptor inhibitor with antitumor activity in CRPC. There's a [...]
XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces developing metastases or death
Non-metastatic Castrate Resistant prostate cancer patients take note. The Phase 3 PROSPER trial in patients with non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC) showed that the use of XTANDI® (enzalutamide) plus androgen deprivation therapy (ADT) [...]